Search tips
Search criteria 


Logo of acgcaserepsLink to Publisher's site
ACG Case Rep J. 2017; 4: e43.
Published online 2017 March 15. doi:  10.14309/crj.2017.43
PMCID: PMC5356152

Severe Cytomegalovirus Gastritis During Natalizumab-Mediated Immunosuppression


We report a 35-year-old female receiving natalizumab as monotherapy for multiple sclerosis who subsequently developed severe cytomegalovirus gastritis. As cytomegalovirus gastritis has not been previously described during natalizumab treatment, we discuss the biological plausibility of this potential association and avenues for further study.

Articles from ACG Case Reports Journal are provided here courtesy of American College of Gastroenterology